Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04070443
Title Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase (TIPI)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications

chronic myeloid leukemia

Therapies

Imatinib + Ponatinib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.